rs371258305

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS1

The NM_139343.3(BIN1):​c.906C>T​(p.Gly302Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000326 in 1,594,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

BIN1
NM_139343.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.337

Publications

0 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • centronuclear myopathy
    Inheritance: SD, AR, AD Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 2-127059107-G-A is Benign according to our data. Variant chr2-127059107-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 262480.
BP7
Synonymous conserved (PhyloP=0.337 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000296 (45/152220) while in subpopulation NFE AF = 0.000544 (37/67994). AF 95% confidence interval is 0.000405. There are 0 homozygotes in GnomAd4. There are 23 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139343.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
NM_139343.3
MANE Select
c.906C>Tp.Gly302Gly
synonymous
Exon 11 of 19NP_647593.1
BIN1
NM_001320642.1
c.825C>Tp.Gly275Gly
synonymous
Exon 11 of 19NP_001307571.1
BIN1
NM_001320641.2
c.813C>Tp.Gly271Gly
synonymous
Exon 10 of 18NP_001307570.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
ENST00000316724.10
TSL:1 MANE Select
c.906C>Tp.Gly302Gly
synonymous
Exon 11 of 19ENSP00000316779.5
BIN1
ENST00000357970.7
TSL:1
c.906C>Tp.Gly302Gly
synonymous
Exon 11 of 18ENSP00000350654.3
BIN1
ENST00000346226.7
TSL:1
c.813C>Tp.Gly271Gly
synonymous
Exon 10 of 16ENSP00000315411.3

Frequencies

GnomAD3 genomes
AF:
0.000296
AC:
45
AN:
152102
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000211
AC:
45
AN:
213738
AF XY:
0.000208
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000465
Gnomad NFE exome
AF:
0.000357
Gnomad OTH exome
AF:
0.000556
GnomAD4 exome
AF:
0.000329
AC:
475
AN:
1442184
Hom.:
0
Cov.:
35
AF XY:
0.000327
AC XY:
234
AN XY:
715396
show subpopulations
African (AFR)
AF:
0.0000601
AC:
2
AN:
33254
American (AMR)
AF:
0.00
AC:
0
AN:
41820
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39034
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82608
European-Finnish (FIN)
AF:
0.000687
AC:
35
AN:
50920
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.000384
AC:
424
AN:
1103468
Other (OTH)
AF:
0.000234
AC:
14
AN:
59706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
28
56
85
113
141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000296
AC:
45
AN:
152220
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41526
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
67994
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000357
Hom.:
0
Bravo
AF:
0.000242

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Myopathy, centronuclear, 2 (2)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
9.4
DANN
Benign
0.81
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371258305; hg19: chr2-127816683; API